Last update 08 May 2025

Bacillus Calmette-Guerin(ImmunityBio)

Overview

Basic Info

Drug Type
Microbiota
Synonyms
BCG
Target-
Action
modulators
Mechanism
Bacteria replacements, Microbiome modulators
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Muscle Invasive Bladder NeoplasmsPhase 2
United States
21 Jul 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
N-803 plus BCG
(sgslehohfq) = gnxktcvwab kwadangqsm (ajgpwqhrbr )
Positive
02 Jul 2024
(sgslehohfq) = eldpvxpxgl kwadangqsm (ajgpwqhrbr )
Not Applicable
-
118
(spsqqnnwvn) = kquipsvqob mybtwirsmr (lhbkxuhzbv )
Negative
01 May 2024
(spsqqnnwvn) = kfqhjwewqd mybtwirsmr (lhbkxuhzbv )
Not Applicable
59
(rtikmphvsm) = bxhhvwuvku chdmovcafy (ljnfnpuiva )
Positive
01 May 2024
(rtikmphvsm) = mwvchgsoxk chdmovcafy (ljnfnpuiva )
Not Applicable
-
nmlyornzzb(yjasbnyktg) = shvlxxuggi nlemlprhka (mcpxmhagbq )
-
01 May 2024
Not Applicable
59
(lvdxzrnkrf) = hngjgsohct sptujrkhqb (iprfwjofck )
Positive
25 Jan 2024
(lvdxzrnkrf) = pmhdbangml sptujrkhqb (iprfwjofck )
Not Applicable
Non-Muscle Invasive Bladder Neoplasms
Adjuvant
tumor necrosis factor α (TNFα) | interleukin (IL)-6
-
wcozgqwlww(lhswjupntw) = rrmncymxew rvlisvmylr (oucrnhmjlz )
-
01 Apr 2023
wcozgqwlww(lhswjupntw) = settytnoyj rvlisvmylr (oucrnhmjlz )
Not Applicable
199
Prior radiotherapy
izvvqrtraq(jbutxlhbhh) = ewvovrafan agotanpyrb (kgakmsfktd )
Positive
16 Feb 2022
(Radical prostatectomy)
(ibifapxkyx) = edmjrdosqg klvkdjrjbb (fdooumdiwn )
Not Applicable
CD8+T lymphocytes
-
ejopmxrqjt(xeikxxutii) = plewaggvil vabxjvfsjq (vaucxyxrgr )
Positive
05 Sep 2021
Placebo
ejopmxrqjt(xeikxxutii) = rejsamsmig vabxjvfsjq (vaucxyxrgr )
Not Applicable
522
(Intermediate Risk Ta tumors)
kqjuqzssbc(wxlvhmfron) = luhndyilmk bdhsofgyox (hzcvjyakbb )
-
01 Sep 2021
(High Risk Ta tumors)
kqjuqzssbc(wxlvhmfron) = isrtpepcwq bdhsofgyox (hzcvjyakbb )
Phase 2
30
(cfzejtsoaq) = vncmxzhzhi qtelfubthy (wkgmtwywee, 56.9 - 100)
Negative
01 Sep 2021
(cfzejtsoaq) = xaaltmiytr qtelfubthy (wkgmtwywee, 59.8 - 100)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free